Abstract Population carrier screening for cystic fibrosis (CF) enables individuals with no known family history of the condition to ascertain their risk of having a child with CF. When an individual is identified as a carrier of CF, a life-shortening condition, they are encouraged to inform their relatives who are at increased risk of being a carrier. Research suggests that the uptake of CF carrier testing amongst relatives of carriers or people with CF is low. This study aimed to explore approaches to facilitate the process of family communication of genetic information after an individual is identified as a carrier of CF through population screening. Five key informants were interviewed to inform the development of a telephone survey which was administered to 21 individuals identified as carriers of CF through population carrier screening at Victorian Clinical Genetics Services. This study suggests that providing carriers with additional information and follow-up support would be appreciated by carriers and could result in more accurate information being disseminated more widely within families, which could lead to more at-risk relatives accessing testing. Suggested strategies to enhance current practice include mailing a fact sheet to carriers and a followup telephone call provided by a genetic counsellor to carriers to offer further support in communicating this information to their relatives.
Introduction
Genetic testing allows for the genetic diagnosis of inherited conditions or for the identification of gene changes that infer an increased risk of developing a condition or passing a condition on to a child. The implications of genetic testing for inherited conditions in one individual are often relevant for other relatives. These can include implications for their own health or may convey information about their reproductive risk of having a child with that condition. It is important that at-risk relatives are provided with necessary information regarding genetic risk to allow them to make informed decisions and access testing should they desire.
Cystic fibrosis (CF) is the most common autosomal recessive condition affecting children in the Caucasian population, with a birth prevalence estimated at 1 in 2500-3500 and a carrier frequency of approximately 1 in 25 (Southern et al. 2007) . It is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene (O'Sullivan and Freedman 2009) and primarily affects the respiratory and gastrointestinal systems. Carrier testing can be performed in order to identify carriers of CF who, if their partner is also a carrier, are at a 1 in 4 (25%) risk for each pregnancy of having a child affected with CF. Due to the high carrier frequency of CF and the fact that most patients with CF are born in families with no known family history of the condition (Boulton et al. 1996; McClaren et al. 2011) , population-based CF carrier screening, the screening of those who have no known family history of the condition, is recommended in many countries including Australia and New Zealand, the USA, the UK and a number of other countries and regions in Europe (American College of Obstetricians and Gynecologists Committee on Genetics 2011; Castellani and Massie 2010 ; Human Genetics Society of Australasia 2010; Southern and Littlewood 2003; Wagener et al. 2012) .
When an individual is aware that they are a carrier, cascade testing of their at-risk family members can occur (Massie and Clements 2005) . Most research in this area, primarily in the context of cascade testing following a diagnosis of CF in a newborn, suggests that family communication of genetic risk information following the identification of a carrier of CF does occur, however usually not to all relevant relatives and subsequent cascade family testing is low (Clausen et al. 1996; Ioannou et al. 2010 ; Lewis et al. 2006; McClaren et al. 2010; Ormond et al. 2003; Watson et al. 1992) .
The practice of genetic counselling involves facilitating communication of genetic risk information. Previous studies have demonstrated that interventions to assist with communication of genetic information about CF can be successful (Lafayette et al. 1999; Sorenson et al. 1997; Super et al. 1994) . Genetic counselling interventions for dominant genetic conditions have also been successful in increasing family communication and thus providing relatives access to genetic services (Forrest et al. 2008; Segal et al. 2004; Suthers et al. 2006) . Family communication of dominant genetic disorders is likely to be different to communication of carrier information due to the direct impact of the condition on the individual. However, it is possible to learn from these interventions and adapt them to family communication of genetic risk information for reproductive carrier testing.
Few studies have examined family communication after CF carrier identification through population screening (Ioannou et al. 2010; Ormond et al. 2003) ; however, it is expected that cascade testing in this setting would also be low, particularly in the absence of an affected proband. An opportunity exists to assist carriers of CF identified through population carrier screening with passing the genetic information on to their relatives. As carrier testing for recessive genetic conditions is becoming increasingly more available particularly through panels offering screening for a large number of inherited conditions, given the high carrier frequency for CF, the number of individuals aware of their CF carrier status will continue to increase. This highlights the need to investigate how familial implications of this information are being managed so that carriers are well supported to disseminate the information around the family.
This pilot study aimed to examine approaches to assist individuals with communicating genetic risk information to their relatives and subsequent access to genetic services by relatives, following the identification of a CF carrier through population carrier screening in one clinical genetics centre in Victoria, Australia.
Method
This study was approved by the Royal Children's Hospital (RCH) Human Research Ethics Committee (HREC 33267 A) and registered with the University of Melbourne Health Sciences Human Ethics Sub-Committee.
Study setting
In 2006, Victorian Clinical Genetics Services (VCGS) began offering population carrier screening for CF in Victoria, Australia (Massie et al. 2009 ). Screening was available to individuals and couples pre-pregnancy or early in pregnancy (generally 12 weeks gestation or less) and was offered by obstetricians, general practitioners, and fertility specialists. The test initially had a detection sensitivity of 80% using a 12-mutation panel (Massie et al. 2009 ) and then moved to a 38-mutation panel with a 90% detection sensitivity for carriers in the Australian Caucasian population (Archibald et al. 2014) . In the first 7 years that the carrier screening program was available, approximately 10,000 people were screened with approximately 1 in 33 identified as carriers (Archibald et al. 2014) .
People offered screening were given an information brochure and test kit with screening predominantly performed on buccal samples. If an individual was identified as a carrier of CF, a VCGS genetic counsellor contacted the referring doctor to discuss the results and offered to provide genetic counselling for the patient. This involved discussion of genetics and inheritance of CF, arranging partner testing, disclosure of the partner's result, discussion of reproductive options for carrier couples, and discussion of cascade testing. In addition, the carrier received a family letter that could be circulated to relatives explaining how to access carrier testing. Although some doctors opted to manage the results themselves, in the vast majority of cases, a VCGS genetic counsellor was involved. If the partner of a CF carrier received a negative test (low risk) result, no further telephone contact was made after disclosure of the result and the couple receive a letter summarising their results. CF carrier couples were offered a genetic counselling consultation, an appointment with a respiratory physician to discuss CF, and CF prenatal diagnosis was discussed with pregnant couples. CF carrier screening is becoming increasingly available in Victoria through other private pathology services and is now usually preformed as part of expanded carrier screening panels. These services issue the carrier result to the referring doctor, and the referring doctor either refers the patient to a clinical genetics service or manages the genetic counselling themselves.
Study design
A two-phase approach was utilised in this study; semistructured interviews with key informant (KI) experts were conducted to explore possible approaches that could be taken to assist with family communication after CF population carrier screening. From these interviews, a survey was developed for distribution to carriers identified through CF population screening.
Key informant interviews
A key informant is usually in a role that means they possess knowledge relevant to the research. They can therefore provide an expert source of information and are used to provide an in-depth insight into their field (Marshall 1996) . The key informant (KI) interviews were held with experts in the following categories: genetics staff currently or previously involved in CF population carrier screening at VCGS; staff at the Cystic Fibrosis Victoria (CFV) support group; and staff from the Respiratory Medicine Department at the Royal Children's Hospital, Victoria, involved with care of individuals affected with CF. Interviews were conducted face-to-face and were semi-structured, with questions developed from previous research as well as the experience of the research team (Forrest et al. 2008; Ioannou et al. 2010; Segal et al. 2004; Suthers et al. 2006 ). Interviews were audio-recorded and transcribed verbatim. Content analysis (Elo and Kyngäs 2008) was used to analyse the data and a survey was drafted based on the KI interview findings and previous literature (Forrest et al. 2008; Segal et al. 2004; Suthers et al. 2006 ).
Telephone survey
The survey included demographic information and closed and open questions, to gain quantifiable data on the family communication occurring after a carrier of CF is identified and to explore participants' thoughts on the different approaches that could be used to assist family communication. KIs were invited to provide feedback on the draft survey and changes were incorporated into the final version.
An invitation to participate in the telephone survey was sent to carriers of CF identified through the VCGS CF carrier screening program between 2011 and 2012. To be eligible, their partner must have been tested and not identified as a carrier for any of the mutations tested. We did not include carrier couples because they had recently been recruited to participate in another study (Ioannou et al. 2015) . The recruitment process is outlined in Fig. 1 . Respondents were English speaking, over 18 years of age, deemed able to provide voluntary and informed consent and had some contact with a genetic counsellor at VCGS during the screening process, so that it was clear the person was aware of their result.
The survey was researcher-administered by telephone and the session was audio-recorded so that open-ended responses could be transcribed verbatim. Responses from closed questions were entered into a Microsoft Excel database and tables were created to generate descriptive statistics. Transcripts of open-ended responses were analysed using inductive content analysis (Elo and Kyngäs 2008) .
Results

Key informant interviews
Five KIs participated in an interview: a geneticist, a CF physician, a genetic counsellor, a nurse and a support group staff member. KIs' perceptions of usefulness and feasibility of approaches to facilitate communication of genetic risk information are listed in Table 1 . During the first KI interview, in addition to the six possible approaches proposed by the researcher, a seventh approach (approach G) was raised, which was added to subsequent KI interviews.
The five KIs discussed the need for further education for health professionals and/or the general population, about CF and the availability of the screening test. They believed it would be important to refresh a carrier's knowledge, provide additional follow-up support, and provide carriers with accurate and relevant information for their reference.
The approaches well received by KIs with regard to their feasibility and usefulness in facilitating communication of genetic information from carriers to relatives (A, C, E, G) were included in the survey for phase 2.
Telephone survey
As summarised in Fig. 1 , 60 potential participants (beginning with those who had their test most recently between 2011 and 2012), identified in the CF carrier screening database, who met the eligibility criteria, were invited to participate. It had been 2-3 years since they received their results. A total of 21 participants consented to be involved in the study, giving a response rate of 35%.
The demographics are presented in Table 2 . The participants were predominately female, aged 30-34 years old and had completed tertiary education. At the time of the survey, most participants had one child and almost all reported that they had no known family history of CF.
Responses for knowledge questions are summarised in Table 3 . Overall, participants performed well on the knowledge questions.
Almost all of the study participants reported speaking with relative(s) about their increased risk of being a carrier of CF, most commonly with a sibling and parent. Very few participants reported speaking with a first cousin or aunt/uncle. Most participants who spoke to their relatives recommended that the relative should have the screening test. Only four participants reported knowing of a sibling who has since had the CF screening test and one of these participants also reported a parent having the test.
When asked to explain why they had discussed the genetic risk information with relatives, participants described multiple reasons, including the relative being of or nearing child bearing age; providing general awareness for the family; perceived severity of CF; for relatives to share the information with their own children; and to identify the origin of the mutation.
When describing reasons for not discussing the genetic risk information with relatives, some participants initially responded that there would be no reason to not communicate the information. However, the majority of participants subsequently reported one or more reason/s why they may not have communicated to some relatives. The reasons reported include the stage of life of the relative/s-the relative/s had finished having children or did not plan to have children; being estranged or geographically distant from the relative; perceived difficulty of having the conversation; and not being aware of the relevance of the information for relatives more distantly related than siblings.
One participant did not disseminate the information to any relatives and reported this was because carrier testing had been distressing for her and her partner and she saw no benefit associated with testing.
Participants described, in their own words, the main reasons they chose to have the CF screening test. Participants reported multiple reasons, including a recommendation from their doctor; perceived severity of CF; and because they wanted to do anything they could for the health of their future children. The results below provide insight into participants' views on possible approaches to assist with family communication of genetic information and Table 4 summarises how many participants felt each approach would be useful.
Approach A: follow-up phone call from genetic counsellor Most participants felt they would have appreciated a followup phone call from a GC. Many thought this approach may be reassuring and felt that people would value the opportunity to ask further questions after the initial surprise at receiving a carrier result had subsided:
To get reassurance again from someone who understands CF. P5 Yes, that would be helpful because once you absorb it then you come up with other questions. On the day that you get told you're a carrier, you're freaking out…you only absorb so much. P21
Some participants also thought that this approach would be helpful as a reminder or prompt to speak with relatives:
I think especially through pregnancy when you go through so many tests and everything, it's probably a nice prompt to remind people to do it. P7 A telephone call from a genetic counsellor to the carrier after the carrier's partner had received their results, to explore how they were coping and enquire whether they required further assistance with family communication.
Believed it was a good idea to refresh carriers' knowledge and provide additional support once the stress had subsided. KI3: BOften people just deal with the implications for themselves at the time, and they can't think about the implications for others yet at that time. So maybe it is good to come back to it some time later, not too much later.Â pproach B Follow-up letter Mailing a letter after the initial summary and family letters, to provide more information about genetic testing for relatives and to act as a reminder.
Did not believe this would be worthwhile, believed the letters currently sent are adequate and an additional phone call would have more impact than an additional letter. KI1: BMy guess is this would make very little difference.Â
pproach C Information pack
Brochures and pamphlets mailed to carriers including information about CF, descriptions of which relatives are at increased risk and information on communicating with relatives.
3 KIs felt this would be useful, to provide carriers access to accurate information. All reported it would be useful to provide information explaining which relatives are at increased risk of being a carrier. KI4: BYes I think that would be really important… so people appreciate what it's like and the variability.Â
pproach D Offer of appointment
An offer to the carrier of a face-to-face appointment with a genetic counsellor, approximately 1 year after the test.
All agreed in theory this would be useful, but felt it would not be a good use of resources and that the uptake would be low. KI2: BWe moved from face-to-face counselling to mainly over the phone and no-one has ever actually asked for face-to-face counselling.Â
pproach E Online information
More online information made available to carriers.
All believed this would be useful to provide access to accurate, relevant information. KI2: BAbsolutely. People will access it.Â pproach F Support group involvement CF support group(s) providing information for carriers and promoting awareness of carrier screening.
All reported that CFV has accurate information and could help with public awareness about carrier screening. However, three KIs believed this may be challenging for a CF support organisation. KI3: BThat may be difficult for a support group because they would have to have information there about couples choosing not to continue a pregnancy.Â
pproach G Direct contact
A letter sent from the genetics service directly to relatives, stating that someone in the family had been found to be a carrier of CF with details about how to access carrier testing.
KIs believed this would be a successful way of providing relatives with information and increasing access to genetics services. They did not believe there would be a problem with privacy issues if the carrier gave consent. KI1: BUnquestionably the best way to do it is for the genetic team to ring the family members, it has been done and it works…or send letters…I think it is ethical, in an ideal world it should happen.Ĉ F cystic fibrosis, CFV Cystic Fibrosis Victoria (support group)
It was so stressful at the time and then we got his [partner's] results and it was just kind of brushed under the carpet. I think having that follow-up phone call to talk it through and debrief a little bit would have helped me deal with it and then I could have been more proactive about passing that on. P17
Participants who thought this approach would be useful were asked about the best timing for the phone call. Most suggested within a couple of weeks of partner result disclosure, as the information is still recent but they have had some time to absorb the news.
Approach C: information mailed out
Participants who felt additional written information would have been useful mentioned that providing information on exactly who in the family they should disseminate the information to would be helpful:
My gut instinct was to tell someone who would be likely to have another baby. I didn't really think about the benefit of telling everyone in the family. P1
Some participants discussed that online information would be a better avenue than printed brochures:
I don't think people would necessarily read it. If people were interested in that information I think now they'd be on the internet. P4
Others believed printed brochures would be useful, mainly for ease of passing the printed information to relatives to read:
A brochure on it would have been good because then you can give [it to] whoever you're handing the letter to, you know, this is what it actually is, not just a letter saying you need to get this done, when they don't necessarily know what cystic fibrosis actually is or what it means. P21 Approach E: online information/website for carriers Participants were asked about online information-a website developed for carriers or a list of good websites provided to them and most responded positively to this approach. (90) a These individuals would have been told that they Btested negative^for the mutations on the panel that the laboratory uses. BNon-carrier^is not used as they have not been tested for all possible CFTR gene mutations b After the first four surveys, the phrasing of this question was altered during the interview to ensure participants understood that we were asking them, based on their and their partner's test results, which relatives are at an increased chance of being CF carriers Participants acknowledged that currently most people gather information on the Internet; however, it can be difficult to know which online sources to trust:
When you take that phone call, it's a lot of things to process and my family were asking questions and I got confused with all the stats so if it was all outlined clearly at a website… website or just point you in the right direction…that would have been helpful. P2
Some participants also suggested internet sources were useful to provide information to relatives:
I could give it to them directly rather than my version of paraphrasing what I had heard or read. P16
Participants were then asked what information they would like to be able to access online. Responses included relevant statistics and risks; what it means to be a carrier of CF, including that there are no health implications for carriers; information about the disease and treatments; who in the family to discuss the information with; and the implications of testing. There was an emphasis on the need for the information to be simple and concise.
Approach G: letter sent from genetics service to family members Almost all participants reported they would not have appreciated a letter to be sent from genetic services to their family members, mainly because they preferred to be the person to communicate the information to their relatives. There was concern that the letter would not be trusted or read and many did not want an anonymous letter sent to relatives without first informing them:
I think that news like that are better accepted when they come from a family member… if you can provide the carrier with enough tools and information to be able to pass that information on to their family that is a better option. P16
Those who thought the idea could be a good method of providing information to relatives suggested they would still want to first inform their relatives. Some participants appreciated this could be a useful approach when families are estranged or do not feel comfortable communicating this information and suggested to provide this as an option to carriers.
Discussion
This study has addressed expert and carrier views regarding various approaches that could be adopted to assist family communication of genetic information after an individual is identified as a carrier of CF through population carrier screening. Approaches favoured were a follow-up telephone call from a genetic counsellor; provision of additional written materials; and provision of reputable websites that can be accessed by carriers and their relatives.
Research has suggested that many relatives are not receiving sufficient information to be able to make an informed decision regarding CF testing (McClaren et al. 2013) or testing for other conditions (Claes et al. 2002) ; findings from the current study support this assertion. It may also be that relatives do not understand the benefits of screening for themselves; relatives of children diagnosed with CF by newborn screening cite the main reasons for not seeking carrier testing for themselves to be perceiving it to not be relevant (yet) and lacking awareness of the availability of testing for them (McClaren et al. 2013) . It is likely that relatives of carriers identified through population screening will have similar views and may be even less likely to seek information and/ or testing for themselves as they do not have personal experience of CF which may influence their interest in screening (Archibald and McClaren 2012) . Providing more information that includes the possible benefits of screening could assist with ensuring relatives are making an informed decision about their own CF testing. The importance of investigating approaches to facilitate family communication by carriers of CF has been recommended (McClaren et al. 2013) .
As reported by carriers in the current study and other studies, the initial phone call disclosing the test result elicits a level Letter from genetic service to family members (approach G) Useful 2 (10) Not useful 19 (90) of shock and is often recalled as a particularly stressful time (Myring et al. 2011 ). Shock and anxiety may limit an individual's absorption and recollection of information discussed (McClaren et al. 2013) . Many experienced this feeling of shock, even though it is common to be a carrier of a recessive condition. This may reflect a lack of awareness about how common it is to be a carrier of a genetic condition. Additionally, people may not be well prepared for these results, as they are not receiving adequate pre-test counselling for this population screening. In our study and others, most carriers were pregnant at the time of screening (Ioannou et al. 2010) , which may also have led to feelings of shock as they were anxious about the implications of this result for their pregnancy. There are different models of offering carrier screening for recessive conditions, and one model that could be a solution to this is to offer parallel testing of both partners, where the male's sample is only processed if the female is found to be a carrier. As participants of this study were pregnant, genetic counselling focused on discussing the risks for the couple and little attention may be directed to consideration of risks for relatives while other priorities are dealt with. Carriers in this study felt they would have appreciated an additional discussion with a genetic counsellor after the initial shock had subsided.
Both KIs and carriers agreed it was important to provide carriers with information about for whom in the family the genetic risk information is most pertinent. Participants spoke of going with their gut instinct of talking with close relatives (i.e. siblings) who were likely or thinking of having (more) children. Studies have proposed identifying at-risk relatives and clarifying this with the affected or carrier individual (Daly et al. 2001; McConkie-Rosell et al. 1995) . Explicitly providing this information could facilitate wider communication through the family.
An important part of facilitating family communication is education for the individual (Daly et al. 2001) . Most participants felt that it would have been useful to be provided with accurate and easily accessible information, both for themselves and to pass on to relatives. Previous research has suggested a link between the disclosure of genetic risk information to family members and how the individual believes the relative will cope with the information (Featherstone et al. 2006) . Making available written material as a reference is believed to assist with family communication (Claes et al. 2002; Daly et al. 2001 ) and having information readily available for the relatives may alleviate some of the burden felt by individuals in assisting their family member to cope with the information. The findings from the present study suggest a useful approach could be a one-page fact sheet sent out to carriers with the current letters and made available online. The fact sheet could outline which relatives are at-risk of being a carrier, why it is important to communicate genetic risk information with them and what information to disseminate. CFV, together with authors BM and AA, now have available a fact sheet for talking to relatives both adults and young people about carrier testing. (https://www.cysticfibrosis.org.au/media/wysiwyg/ VIC/PDFs/CFV_DiscussAdults_2015-6-24.pdf).
Many survey participants believed that a follow-up phone call to the carrier, a few weeks after the partner's results had been disclosed and the shock had subsided, would be a useful approach. As discussed by participants in the current study, the phone call could act to reinforce and clarify information, which has been suggested as a useful strategy (Daly et al. 2001; McClaren et al. 2013) . The implementation of followup phone calls has previously proved successful in increasing the number of relatives informed of their genetic risk and presenting for testing (Forrest et al. 2008 ). However, consideration should be given to the resource implications of adding such an intervention into the carrier screening process.
Overall, participants did not believe they would have appreciated the genetics service sending a letter directly to their relatives. This approach was first raised by one KI and supported by others, as a potentially successful method of informing relatives of their risk. This intervention has been used successfully in a cancer setting (Suthers et al. 2006 ). Participants felt they should be the person to initially disclose the information to their relatives, which has also been suggested elsewhere (Forrest et al. 2003; McConkie-Rosell et al. 1995) .
Limitations of the study
Several limitations should be taken into consideration. As the CF carrier screening involves an out-of-pocket cost for the consumer and is not offered by all family doctors (general practitioners, GPs) or obstetricians, the target population for the current study is most likely not representative of the wider Australian population. Moreover, the present study only invited individuals-who were highly educated-from one Victorian carrier screening program to participate and different programs may involve different processes. Additionally, when the test is ordered by a GP or obstetrician and not referred for genetic counselling, it is unclear if there is any discussion about the familial implications. As such, the results of this study may not be able to be extrapolated to all carrier screening programs. For the above-mentioned reasons, further research needs to be conducted and the results of this study are not generalisable.
One issue that was not explored in this study was to what extent the participants utilised the family letter provided to them and how many of their relatives received the letter and acted on it by requesting carrier testing. This could be explored in future research to identify if the family letter is a useful resource.
While this study has provided useful information about the current process of CF carrier screening and subsequent family communication, it is limited by the number of participants.
The smaller numbers limit generalisability but do give insight into the range of responses to the approaches and a solid foundation for future research. This pilot survey could be rolled out to a larger cohort of carriers.
Conclusion
This study provides further evidence that family communication is most commonly occurring between first-degree relatives and subsequent cascade testing is low. Participants of the current study would have appreciated additional support and information to assist them with the communication process. Participants believe they should be the person to inform relatives of the genetic risk and would like to be provided with more tools to do so. The suggested changes could enhance the current process of follow-up for population-based carrier screening programs, by increasing the accuracy of the information disseminated and the number of relatives informed. As expanded carrier screening panels become increasingly available, with a high proportion of those screened receiving a carrier result for at least one inherited condition, the management of family communication and cascade testing after identification of carriers is an important consideration and should be factored into the design of any carrier screening program. While the small numbers of this study limit generalisability, they suggest some important issues that should be considered for expanded carrier screening programs and some potential ways to address the issues of family communication of genetic risk information in this arena.
